Clear cell renal cell carcinoma ontogeny and mechanisms of lethality

E Jonasch, CL Walker, WK Rathmell - Nature Reviews Nephrology, 2021 - nature.com
The molecular features that define clear cell renal cell carcinoma (ccRCC) initiation and
progression are being increasingly defined. The TRACERx Renal studies and others that …

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

Y Cheng, C He, M Wang, X Ma, F Mo, S Yang… - Signal transduction and …, 2019 - nature.com
Epigenetic alternations concern heritable yet reversible changes in histone or DNA
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …

Renal cell carcinoma

JJ Hsieh, MP Purdue, S Signoretti, C Swanton… - Nature reviews Disease …, 2017 - nature.com
Renal cell carcinoma (RCC) denotes cancer originated from the renal epithelium and
accounts for> 90% of cancers in the kidney. The disease encompasses> 10 histological and …

Intragenic DNA methylation prevents spurious transcription initiation

F Neri, S Rapelli, A Krepelova, D Incarnato, C Parlato… - Nature, 2017 - nature.com
In mammals, DNA methylation occurs mainly at CpG dinucleotides. Methylation of the
promoter suppresses gene expression, but the functional role of gene-body DNA …

Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results

TA Yap, E Fontana, EK Lee, DR Spigel, M Højgaard… - Nature medicine, 2023 - nature.com
Predictive biomarkers of response are essential to effectively guide targeted cancer
treatment. Ataxia telangiectasia and Rad3-related kinase inhibitors (ATRi) have been shown …

The interplay of histone modifications–writers that read

T Zhang, S Cooper, N Brockdorff - EMBO reports, 2015 - embopress.org
Histones are subject to a vast array of posttranslational modifications including acetylation,
methylation, phosphorylation, and ubiquitylation. The writers of these modifications play …

Metastasis as an evolutionary process

S Turajlic, C Swanton - Science, 2016 - science.org
Therapeutic advances in oncology have not fully translated to the treatment of metastatic
disease, which remains largely incurable. Metastatic subclones can emerge both early and …

[HTML][HTML] Inhibiting WEE1 selectively kills histone H3K36me3-deficient cancers by dNTP starvation

SX Pfister, E Markkanen, Y Jiang, S Sarkar… - Cancer cell, 2015 - cell.com
Summary Histone H3K36 trimethylation (H3K36me3) is frequently lost in multiple cancer
types, identifying it as an important therapeutic target. Here we identify a synthetic lethal …

Choosing the right cell line for renal cell cancer research

KK Brodaczewska, C Szczylik, M Fiedorowicz, C Porta… - Molecular cancer, 2016 - Springer
Cell lines are still a tool of choice for many fields of biomedical research, including oncology.
Although cancer is a very complex disease, many discoveries have been made using …

Clustered mutation signatures reveal that error-prone DNA repair targets mutations to active genes

F Supek, B Lehner - Cell, 2017 - cell.com
Many processes can cause the same nucleotide change in a genome, making the
identification of the mechanisms causing mutations a difficult challenge. Here, we show that …